MHRA approves weight loss jab Wegovy to ‘prevent’ heart problems in UK ‘first’
The medicines regulator has approved the use of semaglutide injections to “reduce the risk” of “serious heart problems” in overweight adults.
The medicines regulator has approved the use of semaglutide injections to “reduce the risk” of “serious heart problems” in overweight adults.